1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Recent studies of FD treatment in acute SAH in specific conditions
Authors Publication Date Aneurysm Type No. of Patients/Mean Age Treatments Results/Occlusion Rates Complications
Maus et al²⁴ 2018 Dissecting vertebrobasilar 1556 yr 15 IAs, 22 FDSs, treatment within 12 h of SAH onset 36% Directly occluded; 100% occluded on FU 3 (Ischemia, vessel perforation, ongoing active bleeding)
Bhogal et al²² 2018 Small IA (1–4 mm) 760 yr 7 IAs, 8 FDSs, treatment within 6.3 days from SAH (median) 100% Occluded on FU None
Lozupone et al²³ 2018 8 BBAs, 9 dissecting IAs 174 yr 17 IAs, 21 FDs, treatment within 4.2 days (median) 12 of 15 Patients followed-up 12% Mortality;12% morbidity
AlMatter et al²¹ 2019 Saccular (18), fusiform (5), BBA (7), dissecting (15) 4558. 8 yr 45 IAs, FDSs as sole or adjunct device, treatment within 30 days after SAH 94.6% Complete occlusion on follow-up among survivors 13.3%; 2.2% Morbidity; 4.4% mortality
Note:—IA indicates intracranial aneurysm; FDS, flow-diverting stent; FU, follow-up; BBA, blood-blister-like aneurysm; FD, flow diverter.